Market value development

Current research ethics do not adequately address the issue of international research on the diversity of the human genome. Under current research standards, this research will widen the gap between developed and underdeveloped countries. New ethics standards for this research should frame this research so the market value of property rights from such research fosters the development of research institutions, a scientific workforce, and access to investment and venture capital within underdeveloped countries. The 1992 CBD offers just such a foundation. 

The development of a rancid flavor in milk and some other fluid products is usually undesirable and detracts from their market value. In contrast, the popularity of certain dairy products, notably some varieties of cheese, as well as some confectionery items containing milk as an ingredient, is thought to be partially due to the proper intensity of the rancid flavor. Hence, knowledge of the factors involved in the development of rancidity is of great practical importance to several industries. 

Although the economic downturn of 2001-2003 was accompanied by massive losses on the stock markets, this development did not reflect to the same degree in the prices paid for acquisitions in the specialty chemicals sector. Since at the same time the economic outlook for most specialty chemicals markets offered considerably lower growth expectations than in the 1990s, major acquisitions at high multiples seemed an increasingly unattractive option for value generation. 

Each element of the go-to-market value delivery system is likely to require the development of new tools and techniques that enable enhanced transparency and faster and improved fact-based decision making. This starts with enhancing the transparency of customer profitability, to gain an understanding that goes deeper than annual overall profitability by customer and provides transparency by customer, by product, and by transaction. Averages quite often disguise improvement opportunities - 50 percent of transactions are below the annual customer profitability. 

It requires the development of an integrated go-to-market value delivery system based on six elements. 

Nevertheless, improving or even innovating SCM design and operations is a reliable way to boost ROIC and therefore market value, as supply chains link nearly all parts of a company s business system. When Dell developed its radically new supply chain model, it was really thinking out of the box , and probably no one would have believed it would soon become the reference in (and outside) its industry, and one of the biggest and most valuable players in its sector. Similarly, other industries have indicated ways that the chemical industry can take in the near future. 

More than 220 producers of CRMs throughout the world produce today 12,000 20,000 materials with dif ferent matrixes, analytes and properties [4]. However, many testing (analytical) laboratories cannot find suitable CRMs in the market and develop in-house reference materials (IHRMs) themselves. Often IHRMs are developed in a laboratory to conserve the corresponding expensive CRMs. For example, a pharmaceutical company Chemagis Ltd. produces 30 active pharmaceutical ingredients steroids, benzodiazepines, antihistamines, hipolipidaemics, blood flow reactants, etc. Only for a few of them Mo-metasone Furoate, Fluticasone Propionate and Dobutamine Hydrochloride are of fi-cial reference standards for assay supplied by US, British and European Pharmacopoeias with prices of about 180 per unit (50 200 mg). Thus, to support its customers Chemagis is forced to develop IHRMs for assay as well as for impurities and related substances of each produced compound. Therefore, certification of such IHRMs that leads to traceable values is very important. 

The great importance of manufactured fibers in the chemical industry and in the overall economy of the United States (and, in general, the developed countries) becomes apparent when the volume of production of these materials is considered and compared with the market value of even the least expensive of the raw materials used by them. The amounts of oil and natural gas consumed by the manufactured fiber industry represent around 1 percent of national annual usage. 

On the other side of the marketplace equation is the seller the pharmacy, drug wholesaler, or prescription drug manufacturer. Drug manufacturers desire to provide FDA-approved (safe and effective) products developed and manufactured at the lowest possible cost and sell them through the distribution channel at a price that allows for maximum profit. They must sell a product that has a perceived market value equal to or greater than the costs of production, promotion, plus the projected dollars the product makes to the company s anticipated profit. 

The natural trend in drug development will be toward indications of lower incidence, prevalence, and market value. There will be no choice. In addition, attention will have to be increasingly given to individualized medicine. But genomics-based, individualized medicine assumes huge changes in society s attitudes. This will become an enormously interesting debate. 

Solvent-extracted rapeseed oil has been found to contain the highest level of phosphorus. For this reason, it is common practice to degum solvent-extracted oil or the mixed crude oil from pressing and subsequent solvent-extraction. As the double-zero rapeseed varieties such as canola became available, the applications of rapeseed lecithin have developed positively. Where at first rapeseed lecithin was applied as an emulsifier and energy component in animal feed, the recent concerns about GMO soybean varieties in some parts of the world have increased the market value of the softseed lecithins for food applications (45). The phospholipid composition is similar to soybean lecithin with variations due to crop and processing conditions. The rapeseed phospholipid compositions in Table 12 have been confirmed by recent data, whereas the soybean lecithin composition in... 

Pirated copies of full regulatory dossiers have substantial black market value to competitor companies who have used them to leap-frog the original developer to obtain a licence for their unresearched copied molecule. Dossiers may be enormous, even one million pages or the electronic equivalent, the latter being very convenient as it allows instant searching. 

---